Amwell® to report second quarter 2025 operating results; company leaders to attend upcoming investor conferences
Amwell (NYSE: AMWL), a leading SaaS-based healthcare technology platform provider, has scheduled its second quarter 2025 earnings release for August 5 after market close. Management will host a conference call and webcast at 5 p.m. ET to discuss results and provide business updates.
Additionally, company executives will participate in two upcoming investor conferences: CFO/COO Mark Hirschhorn will attend the Wells Fargo Healthcare Conference on September 4 in Boston, while Chairman/CEO Ido Schoenberg and Hirschhorn will join the Morgan Stanley Global Healthcare Conference on September 9 in New York, including a fireside chat at 2:35 p.m. ET.
Amwell (NYSE: AMWL), un importante fornitore di piattaforme tecnologiche sanitarie basate su SaaS, ha programmato la pubblicazione dei risultati del secondo trimestre 2025 per il 5 agosto dopo la chiusura dei mercati. La direzione terrà una conference call e una webcast alle 17:00 ET per discutere i risultati e fornire aggiornamenti aziendali.
Inoltre, i dirigenti dell'azienda parteciperanno a due prossime conferenze per investitori: il CFO/COO Mark Hirschhorn sarà presente alla Wells Fargo Healthcare Conference il 4 settembre a Boston, mentre il Presidente/CEO Ido Schoenberg e Hirschhorn parteciperanno alla Morgan Stanley Global Healthcare Conference il 9 settembre a New York, includendo una conversazione informale alle 14:35 ET.
Amwell (NYSE: AMWL), un proveedor líder de plataformas tecnológicas de salud basadas en SaaS, ha programado la publicación de sus resultados del segundo trimestre de 2025 para el 5 de agosto tras el cierre del mercado. La dirección realizará una llamada conferencia y una transmisión web a las 5 p.m. ET para discutir los resultados y ofrecer actualizaciones comerciales.
Además, los ejecutivos de la empresa participarán en dos próximas conferencias para inversores: el CFO/COO Mark Hirschhorn asistirá a la Conferencia de Salud de Wells Fargo el 4 de septiembre en Boston, mientras que el Presidente/CEO Ido Schoenberg y Hirschhorn participarán en la Conferencia Global de Salud de Morgan Stanley el 9 de septiembre en Nueva York, incluyendo una charla informal a las 2:35 p.m. ET.
Amwell (NYSE: AMWL)은 선도적인 SaaS 기반 헬스케어 기술 플랫폼 제공업체로, 2025년 2분기 실적 발표를 8월 5일 시장 마감 후로 예정했습니다. 경영진은 오후 5시(동부시간)에 실적 논의 및 사업 업데이트를 위한 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다.
또한, 회사 임원들은 두 개의 투자자 컨퍼런스에 참여할 예정입니다: CFO/COO Mark Hirschhorn은 9월 4일 보스턴에서 열리는 웰스파고 헬스케어 컨퍼런스에 참석하며, 회장 겸 CEO Ido Schoenberg와 Hirschhorn은 9월 9일 뉴욕에서 개최되는 모건 스탠리 글로벌 헬스케어 컨퍼런스에 참석하여 오후 2시 35분(동부시간)에 파이어사이드 채팅을 진행할 예정입니다.
Amwell (NYSE : AMWL), un fournisseur leader de plateformes technologiques de santé basées sur le SaaS, a programmé la publication des résultats du deuxième trimestre 2025 pour le 5 août après la clôture des marchés. La direction tiendra une conférence téléphonique et une webdiffusion à 17h00 ET pour discuter des résultats et fournir des mises à jour commerciales.
De plus, les dirigeants de l'entreprise participeront à deux prochaines conférences pour investisseurs : le CFO/COO Mark Hirschhorn assistera à la Wells Fargo Healthcare Conference le 4 septembre à Boston, tandis que le président-directeur général Ido Schoenberg et Hirschhorn participeront à la Morgan Stanley Global Healthcare Conference le 9 septembre à New York, incluant une discussion informelle à 14h35 ET.
Amwell (NYSE: AMWL), ein führender Anbieter von SaaS-basierten Healthcare-Technologieplattformen, hat die Veröffentlichung der Ergebnisse für das zweite Quartal 2025 für den 5. August nach Börsenschluss geplant. Das Management wird um 17:00 Uhr ET eine Telefonkonferenz und ein Webcast abhalten, um die Ergebnisse zu besprechen und Geschäftsaktualisierungen zu geben.
Zusätzlich werden Unternehmensleiter an zwei bevorstehenden Investorenkonferenzen teilnehmen: CFO/COO Mark Hirschhorn wird an der Wells Fargo Healthcare Conference am 4. September in Boston teilnehmen, während Vorsitzender/CEO Ido Schoenberg und Hirschhorn an der Morgan Stanley Global Healthcare Conference am 9. September in New York teilnehmen, einschließlich eines Fireside Chats um 14:35 Uhr ET.
- None.
- None.
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2025 operating results after stock market trading hours on Tuesday, Aug. 5.
Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update.
The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell.com for approximately 90 days.
In addition, company executives will attend these upcoming investor conferences:
- Mark Hirschhorn, CFO and COO, will participate in one-on-one meetings at the Wells Fargo Healthcare Conference on Sept. 4 in Boston.
- Ido Schoenberg, Chairman and CEO, and Mark Hirschhorn, will participate in one-on-one meetings and a 2:35 p.m. ET fireside chat at the Morgan Stanley Global Healthcare Conference on Sept. 9 in New York.
An audio webcast of the fireside chat will be available at investors.amwell.com.
About Amwell
Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.
Investors:
Sue Dooley
415.602.9167
Media:
FAQ
When will Amwell (AMWL) report Q2 2025 earnings?
Where can I access Amwell's Q2 2025 earnings webcast?
Which investor conferences will Amwell executives attend in September 2025?
Who will represent Amwell at the Morgan Stanley Global Healthcare Conference?
